Next Generation of Cancer Drug Repurposing: Therapeutic Combination of Aspirin and Oseltamivir Phosphate Potentiates Gemcitabine to Disable Key Survival Pathways Critical for Pancreatic Cancer Progression

SIMPLE SUMMARY: Drug repurposing in combination with clinical standard chemotherapeutics opens a novel and promising clinical treatment approach for patients with pancreatic cancer. This report presents a novel therapeutic effect of the combination of aspirin and oseltamivir phosphate with chemother...

Descripción completa

Detalles Bibliográficos
Autores principales: Qorri, Bessi, Mokhtari, Reza Bayat, Harless, William W., Szewczuk, Myron R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946854/
https://www.ncbi.nlm.nih.gov/pubmed/35326525
http://dx.doi.org/10.3390/cancers14061374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946854/
https://www.ncbi.nlm.nih.gov/pubmed/35326525
http://dx.doi.org/10.3390/cancers14061374

Ejemplares similares